Ceftobiprole- and ceftaroline-resistant methicillin-resistant Staphylococcus aureus

Antimicrobial Agents and Chemotherapy
Liana C ChanHenry F Chambers

Abstract

The role of mecA mutations in conferring resistance to ceftobiprole and ceftaroline, cephalosporins with anti-methicillin-resistant Staphylococcus aureus (MRSA) activity, was determined with MRSA strains COL and SF8300. The SF8300 ceftaroline-passaged mutant carried a single mecA mutation, E447K (E-to-K change at position 447), and expressed low-level resistance. This mutation in COL conferred high-level resistance to ceftobiprole but only low-level resistance to ceftaroline. The COL ceftaroline-passaged mutant, which expressed high-level resistance to ceftobiprole and ceftaroline, had mutations in pbp2, pbp4, and gdpP but not mecA.

References

Apr 1, 1988·Clinical Microbiology Reviews·H F Chambers
Oct 22, 2002·Nature Structural Biology·Daniel Lim, Natalie C J Strynadka
Mar 6, 2004·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Yuki KatayamaHenry F Chambers
May 6, 2005·Journal of Clinical Microbiology·Yuki KatayamaHenry F Chambers
Mar 10, 2006·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·H F Chambers
Apr 2, 2008·Antimicrobial Agents and Chemotherapy·Ritu BanerjeeHenry F Chambers
May 15, 2008·The Annals of Pharmacotherapy·Shawn D Anderson, John G Gums
Oct 20, 2010·Therapeutics and Clinical Risk Management·April Barbour, Hartmut Derendorf
Nov 16, 2010·Drugs of Today·J A Bazan, S I Martin
Mar 9, 2012·The Journal of Antimicrobial Chemotherapy·Rodrigo E MendesKlaudia Kosowska-Shick
Jul 4, 2012·Current Opinion in Pharmacology·Karen Bush
Jul 21, 2012·The Journal of Biological Chemistry·Andrew L LoveringNatalie C J Strynadka
Nov 22, 2012·Expert Review of Anti-infective Therapy·Mark W GarrisonMary M Wen
Oct 3, 2013·Proceedings of the National Academy of Sciences of the United States of America·Lisandro H OteroJuan A Hermoso

❮ Previous
Next ❯

Citations

Jan 15, 2016·Journal of Medicinal Chemistry·Rebecca J AbrahamDarren Trott
Oct 8, 2015·The Journal of Antimicrobial Chemotherapy·Frieder SchaumburgEvgeny A Idelevich
Oct 16, 2015·The Journal of Antimicrobial Chemotherapy·Ewan M HarrisonSharon J Peacock
Jul 21, 2016·Journal of Global Antimicrobial Resistance·Marc Armengol-PortaStefan Monecke
Jun 25, 2016·BMC Microbiology·Carla MottolaManuela Oliveira
Sep 11, 2018·Expert Opinion on Pharmacotherapy·Vicenç FalcóBenito Almirante
Apr 5, 2017·Antimicrobial Agents and Chemotherapy·Stephanie M HamiltonHenry F Chambers
Apr 14, 2016·Antimicrobial Agents and Chemotherapy·Liana C ChanSom S Chatterjee
Oct 31, 2018·Antimicrobial Agents and Chemotherapy·Michael A PfallerHelio S Sader
Jul 23, 2019·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Vladimir GostevSergey Sidorenko
Sep 19, 2019·Antimicrobial Agents and Chemotherapy·Richard R WatkinsMichael Z David
Mar 14, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Yuan-Shuai YangDan-Qing Song
Apr 17, 2019·Frontiers in Microbiology·Mansura S MulaniKarishma R Pardesi
Jan 20, 2018·Emerging Infectious Diseases·Karsten BeckerGeorg Peters
Sep 23, 2020·Antimicrobial Agents and Chemotherapy·Kirill V OvchinnikovDzung B Diep
Mar 10, 2021·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·Elias DahdouhRosa Gómez-Gil
Jan 13, 2021·Antimicrobial Agents and Chemotherapy·Casey L CazerYrjö T Gröhn
Mar 14, 2021·Applied and Environmental Microbiology·Mathias GalliqueNathalie Tufenkji
May 12, 2021·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Nur Najihah Izzati Mat RaniMohd Cairul Iqbal Mohd Amin

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Related Papers

Nihon rinsho. Japanese journal of clinical medicine
Teruyo Ito, Keiichi Hiramatsu
© 2022 Meta ULC. All rights reserved